Decrease in GABA in APP mice. by Ksenia V. Kastanenka (3692380)

Decreased TRAF6 levels are sufficient to impair host control of influenza virus replication. by Carrie M. Rosenberger (42649)

Eltrombopag markedly decreases levels of ROS in MOLM14 cells. by Anna Kalota (7415)

“…B) Graphic presentation of ROS levels measured by flow cytometry in cells treated with E (5 μM) or DPI (25 μM), an inhibitor of NADPH oxidase known to decrease an intracellular level of ROS, or untreated (CTR) cells. …”

VPA decreases cell proliferation. by Muriel Rhinn (406515)

Rapamycin decreases phosphorylation of S6. by Adam L. Hartman (308128)

Resveratrol decreases cell proliferation in a time and dose dependent manner. by Mehtap Kilic Eren (591048)

Resveratrol decreased nitrite production. by André Quincozes-Santos (108426)

PF treatment decreases expressions of cytochrome c and Bax, but increases the expressions of Bcl-2. by Ruo-Bing Guo (298949)

Oral administration of CPE decreased blood glucose level in STZ-induced diabetic mice. by Hisae Yoshitomi (722082)

Subjects:

AMS scores decrease over three days at high-altitude. by Erica C. Heinrich (6832055)

Dexamethasone decreases PGC-1α protein expression and transcription. by Jill A. Rahnert (2872766)

“…<p>(A) Treatment of L6 myotubes with Dex (100nM, 48hrs) decreased PGC-1α protein expression (p = 0.01). n = 3/treatment from 3 experiments. …”

FTY720 decreased viability, proliferation, and motility and induced apoptosis in human hepatoblastoma cells. by Laura L. Stafman (6577184)

“…(B) Following 24 hours of treatment with FTY720, the proliferation of HuH6 cells measured using the CellTiter 96 cell proliferation assay was significantly decreased (IC₅₀ = 6.4 μM, p ≤ 0.05). (C) HuH6 cells were plated and allowed to reach 80% confluence, at which time the media was changed for fresh media (0, 5, or 8 μM FTY720) and a standard scratch wound was made. …”

Chemokines, with the exception of CXCL1 and MCP-1, decrease acutely following 5 Gy IR. by Jordan A. Gunning (18143970)

The novel <i>carboxylesterase 1</i> variant c.662A>G may decrease the bioactivation of oseltamivir in humans by Jaeseong Oh (3947381)

“…A novel <i>CES1</i> c.662A>G single nucleotide polymorphism (SNP) was predicted to decrease CES1 enzymatic activity in an <i>in silico</i> analysis. …”

Stx2 and SubAB decrease HGEC viability. by María M. Amaral (439445)

Madrasin decreases transcription of protein-coding genes. by Michael Tellier (8284752)

L665W decreased AR5A binding to H77/JFH1 particles and to the E1/E2 complex in H77/JFH1 infected cells, but did not alter receptor dependency. by Rodrigo Velázquez-Moctezuma (3776023)

Madrasin decreases transcription of protein-coding genes. by Michael Tellier (8284752)

Increase in intracellular cAMP inhibits decreased RSV A2 F mRNA in epithelial monolayers. by Fariba Rezaee (366381)

HCV infection decreases L1 retrotransposition frequency. by Anja Schöbel (10668438)